TrialCardiovascular diabetology2023

Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study.

Shinji Kishimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.